methylprednisolone acetate has been researched along with Amaurosis in 2 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brill, DA | 1 |
| Fields, TS | 1 |
| Dunn, SP | 1 |
| Ober, MD | 1 |
| Shafir, R | 1 |
| Cohen, M | 1 |
| Gur, E | 1 |
2 other studies available for methylprednisolone acetate and Amaurosis
| Article | Year |
|---|---|
Methylprednisolone Acetate (Depo-Medrol) Injection during Cataract Surgery Causing Retinal Necrosis.
Topics: Aged; Anti-Inflammatory Agents; Blindness; Cataract Extraction; Humans; Injections, Intraocular; Mal | 2019 |
Blindness as a complication of subcutaneous nasal steroid injection.
Topics: Administration, Intranasal; Adult; Anti-Inflammatory Agents; Blindness; Choroid; Edema; Female; Huma | 1999 |